Literature DB >> 2407658

Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum.

L M Kumaratilake1, A Ferrante, C M Rzepczyk.   

Abstract

We developed a radiometric assay by which the antiplasmodial effects of phagocytic cells can be quantitated. This assay was used to examine the effects of recombinant human tumor necrosis factor alpha (TNF-alpha) on the killing of Plasmodium falciparum by human neutrophils. Data presented demonstrated that neutrophils engulf and destroy P. falciparum, but substantial killing of parasites required the presence of either heat-labile or heat-stable opsonins. While recombinant TNF-alpha at concentrations of 5 to 50,000 U/ml showed no direct effects on the parasite, this cytokine augmented the antimalarial activity of neutrophils at doses of 20 to 250 U/10(6) neutrophils. The results suggest that TNF-alpha is an important component of the immune phagocytic effector mechanisms which are involved in destruction of the malarial parasite.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407658      PMCID: PMC258534          DOI: 10.1128/iai.58.3.788-793.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha.

Authors:  I S Figari; N A Mori; M A Palladino
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

2.  Plasmodium falciparum: phagocytosis by polymorphonuclear leukocytes.

Authors:  S Trubowitz; B Masek
Journal:  Science       Date:  1968-10-11       Impact factor: 47.728

3.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

4.  Susceptibility of Plasmodium falciparum to a peroxidase-mediated oxygen-dependent microbicidal system.

Authors:  K Malhotra; D Salmon; J Le Bras; J L Vilde
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

5.  Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites.

Authors:  M Denis; K Chadee
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

6.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

Authors:  J Taverne; J Tavernier; W Fiers; J H Playfair
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  Polymorphonuclear leucocytes defective in oxidative metabolism inhibit in vitro growth of Plasmodium falciparum. Evidence against an oxygen-dependent mechanism.

Authors:  A Kharazmi; S Jepsen; N H Valerius
Journal:  Scand J Immunol       Date:  1984-07       Impact factor: 3.487

8.  Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi.

Authors:  E H De Titto; J R Catterall; J S Remington
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

9.  Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum.

Authors:  D Salmon; J L Vilde; B Andrieu; R Simonovic; J Lebras
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

10.  Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release.

Authors:  A Ferrante
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

View more
  27 in total

1.  Opsonization and phagocytosis of Plasmodium falciparum merozoites measured by flow cytometry.

Authors:  L M Kumaratilake; A Ferrante
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.

Authors:  N S Postma; R C Hermsen; D J Crommelin; W M Eling; J Zuidema
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Enhancement of neutrophil-mediated killing of Plasmodium falciparum asexual blood forms by fatty acids: importance of fatty acid structure.

Authors:  L M Kumaratilake; A Ferrante; B S Robinson; T Jaeger; A Poulos
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Effect of monodesethyl amodiaquine on human polymorphonuclear neutrophil functions in vitro.

Authors:  M T Labro; J el Benna
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

5.  A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice.

Authors:  L M Kumaratilake; D A Rathjen; P Mack; F Widmer; V Prasertsiriroj; A Ferrante
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Serum IL-4, IL-12 and TNF-alpha in malaria: a comparative study associating cytokine responses with severity of disease from the Coastal Districts of Odisha.

Authors:  Anshuman Sarangi; P C Mohapatra; R K Dalai; Ashok Kumar Sarangi
Journal:  J Parasit Dis       Date:  2013-01-09

7.  Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei.

Authors:  L M Kumaratilake; B S Robinson; A Ferrante; A Poulos
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Circulating Neutrophil Extracellular Traps and Neutrophil Activation Are Increased in Proportion to Disease Severity in Human Malaria.

Authors:  Steven Kho; Gabriela Minigo; Benediktus Andries; Leo Leonardo; Pak Prayoga; Jeanne R Poespoprodjo; Enny Kenangalem; Ric N Price; Tonia Woodberry; Nicholas M Anstey; Tsin W Yeo
Journal:  J Infect Dis       Date:  2019-05-24       Impact factor: 5.226

9.  Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies.

Authors:  Charlotte Joos; Laurence Marrama; Hannah E J Polson; Sandra Corre; Antoine-Marie Diatta; Babacar Diouf; Jean-François Trape; Adama Tall; Shirley Longacre; Ronald Perraut
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

10.  Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties.

Authors:  G Luo; D W Niesel; R A Shaban; E A Grimm; G R Klimpel
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.